Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poor
NY Times
OCTOBER 9, 2021
Some poorer countries are paying more and waiting longer for the company’s vaccine than the wealthy — if they have access at all.
NY Times
OCTOBER 9, 2021
Some poorer countries are paying more and waiting longer for the company’s vaccine than the wealthy — if they have access at all.
pharmaphorum
OCTOBER 15, 2021
Digital Health veteran Eugene Borukhovich has joined Healthware Group as senior advisor to its Media and Community business unit, which aims to foster dialogue and connections among the digital health community. He is a serial intra- and entrepreneur, angel investor and venture builder and is currently scaling YourCoach Health as its co-founder and COO.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
OCTOBER 15, 2021
Patients in the trial were those with unresectable hepatocellular carcinoma (HCC) who had not received systemic therapy treatment previously, and were not eligible for localised treatment
Drug Patent Watch
OCTOBER 12, 2021
This paper was originally published by Md. Imtiaz Hasan et al in Journal of Biosciences and Medicines under a Creative Commons Attribution 4.0 International License Abstract Development of generic drug product…. The post Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Marketing Network
OCTOBER 13, 2021
At the 7 th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare conference, top executives from across the pharmaceutical industry gathered to share their personal stories of success and perseverance to educate and inspire the next generation of female leaders. Despite a growing emphasis on diversity & inclusion and a more accepted understanding of the business impact that can be achieved through greater gender balance in organizational leadership, women still
pharmaphorum
OCTOBER 12, 2021
Value-based, person-centred healthcare is the key to system resilience – and now is the time to make it happen. COVID-19 offers a “unique opportunity” to build healthcare systems that are both agile enough to deal with future crises and strong enough to overcome existing challenges. That’s according to a new policy paper from the European Alliance for Value in Health.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
OCTOBER 13, 2021
Tolebrutinib reduced multiple sclerosis (MS) disease activity as measured by MRI
NY Times
OCTOBER 11, 2021
The company is seeking authorization for the pill to be given to high-risk people sick with Covid. Tens of millions of Americans could be eligible.
pharmaphorum
OCTOBER 12, 2021
A data-mining study conducted by researchers in the US has found that an already-approved diuretic drug could have potential as a treatment for some patients with Alzheimer’s disease. The research by a team of National Institutes of Health (NIH) scientists found that people who took bumetanide, a generic drug usually used to treat heart failure and oedema, had a significantly lower prevalence of Alzheimer’s compared to those not taking the drug.
Outsourcing Pharma
OCTOBER 11, 2021
According to two leaders from the healthcare tech firm, improving the way healthcare data is collected, stored, and used can contribute to improved care.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
OCTOBER 14, 2021
The ATTC is coordinated as part of the Cell and Gene Therapy Catapult, and operates within the NHS framework
Drug Channels
OCTOBER 12, 2021
Payers have long sought to disrupt the buy-and-bill channel. Coming out of the pandemic (maybe?), specialty pharmacies—via white, brown, and clear bagging—continue to displace buy-and-bill distribution channels for provider-administered oncology drugs. Check out the latest 2021 data below. The battle for the specialty patient pits hospitals against insurers—and their respective specialty pharmacies.
pharmaphorum
OCTOBER 12, 2021
Roche’s Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to shortages. Now, Sanofi’s rival therapy Kevzara has also been hit by supply constraints. Sanofi said in a statement that supply of all four formats of Kevzara (sarilumab) – 150 mg or 200 mg pre-filled syringes or auto-injectors – will be short until early 2022 based on current demand.
NY Times
OCTOBER 15, 2021
Diagnoses for the disorder have soared in the past decade, driven in part by a loophole in regulations. A new study shows the impact has been more severe for Black Americans.
Pharma Times
OCTOBER 13, 2021
In a Phase III study, the risk of death for advanced RCC patients was decreased by 34% with Cabometyx plus Opdivo treatment
Outsourcing Pharma
OCTOBER 14, 2021
The company has deployed with several healthcare firms, emerged from stealth, named a chief commercial officer, and landed investors backing the technology.
pharmaphorum
OCTOBER 11, 2021
Global Blood Therapeutics (GBT) UK general manager Nigel Nicholls discusses the impact of COVID-19 for sickle cell patients in the UK. If the COVID-19 pandemic has shown us anything, it has highlighted the extent to which health inequity plagues our society. Although the Government, public and health care system have started to wake up to the insidious nature of systemic racism in the wake of the pandemic, many have been left facing tougher situations than pre-pandemic.
NY Times
OCTOBER 14, 2021
Those eligible for the extra shot would include adults over 65 and others at high risk — the same groups now eligible for a Pfizer-BioNTech boost.
Pharma Times
OCTOBER 13, 2021
Conditional marketing authorisation granted for patients with advanced NSCLC with METex14 skipping alterations
Outsourcing Pharma
OCTOBER 11, 2021
The patient-centric platform firm is gathering representatives from different corners of the industry to work on solutions to drive progress and innovation.
pharmaphorum
OCTOBER 13, 2021
This is an exciting opportunity to join pharmaphorum, contributing to our revenue targets, meeting new clients and supporting the development and launch of new offerings within the company’s leading international life science industry publications. This role will give you an excellent opportunity to further develop and sharpen your commercial skills at all angles in a company that is currently expanding.
NY Times
OCTOBER 14, 2021
Confused about who can get a booster shot of which vaccine, and what the F.D.A.’s advisers on vaccines are voting on this week? This scorecard may help.
Pharma Times
OCTOBER 14, 2021
Keytruda plus chemotherapy demonstrated superior overall survival rate in this patient population in the KEYNOTE-826 trial
Outsourcing Pharma
OCTOBER 12, 2021
The AI technology firm and pharma services company are joining to help one of the countryâs leading pharmaceutical firms develop a promising drug candidate.
pharmaphorum
OCTOBER 15, 2021
The World Health Organization has set up a new scientific group to study the origins of COVID-19 in the hope that it will help prevent future pandemics. The new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) will bring together experts from areas such as epidemiology, animal health, clinical medicine, virology and genomics. WHO chief Tedros Adhanom Ghebreyesus said: “SAGO will advise WHO on the development of a global framework to define and guide studies into the origins of
Pharma Marketing Network
OCTOBER 11, 2021
Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Present. Future ,” “Marketing Agility: The Path to Digital Engagement and Innovation, ” and “Digital Health: Where Is It Headed?” While the global outbreak of COVID-19 was the catalyst that pushed Pharma to innovate, think differently, and do things faster, we still aren’t moving fast enough in some areas.
Pharma Times
OCTOBER 12, 2021
Phase Ib CodeBreaK study evaluated Lumakras in over ten different investigational combination regimens
Outsourcing Pharma
OCTOBER 14, 2021
A leader from the pharmaceutical firm talks about some of the most impactful technologies and shares a number of notable advancements made by the company.
pharmaphorum
OCTOBER 10, 2021
Limbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for adolescents with symptoms of depression after reporting positive results in a clinical trial. SparkRx uses a programme of cognitive behavioural therapy (CBT) that is designed to be used alongside treatment by a clinician, and to provide a readily-available intervention for young people when access to interpersonal psychotherapy may be limited.
Drug Channels
OCTOBER 15, 2021
Today’s guest post comes from Jayne Hornung, Chief Clinical Officer at MMIT. Jayne discusses changes in the life science and specialty pharmacy industries since the COVID-19 pandemic began. She highlights three key trends that pharma companies, plan sponsors, and others will consider as we head to the upcoming Asembia Specialty Pharmacy Summit (October 26 to 29 in Las Vegas).
Pharma Times
OCTOBER 11, 2021
Pharmacies saw increased customer demand during the pandemic, says UHY Hacker Young
Outsourcing Pharma
OCTOBER 12, 2021
A leader from the division of Eli Lilly explains the importance of driving greater trial inclusivity, and why collaboration is vital in making progress.
pharmaphorum
OCTOBER 14, 2021
UK-based Big Health has passed a digital health milestone after Scotland became the first country to make anxiety and insomnia digital therapeutics available on a national basis. NHS Scotland will offer the digital health firm’s Sleepio and Daylight, and the cognitive behavioural therapy they provide, to all adults via their GP or online self-referral greatly expanding their previous availability.
NY Times
OCTOBER 14, 2021
A Food and Drug Administration advisory panel recommended a half-dose as a third injection for people 65 and older as well as younger adults at high risk because of their medical conditions or jobs.
Pharma Times
OCTOBER 14, 2021
26 experts have been appointed to join the Scientific Advisory Group on the Origins of Novel Pathogens (Sago)
Let's personalize your content